2023 - Research.com Immunology in United Kingdom Leader Award
Her primary scientific interests are in Antibody, Immunology, Antigen, Molecular biology and Chronic lymphocytic leukemia. Her Antibody research integrates issues from Gene and Immune system. Freda K. Stevenson interconnects Cancer research, Signal transduction and Disease in the investigation of issues within Immunology.
Her studies in Cancer research integrate themes in fields like Phosphorylation and IGHV@. Her Chronic lymphocytic leukemia research incorporates themes from Immunoglobulin M, Germline mutation, breakpoint cluster region and Naive B cell. Her research in Naive B cell intersects with topics in Monoclonal B-cell lymphocytosis and Memory B cell.
Her primary areas of study are Immunology, Antibody, Antigen, Molecular biology and Chronic lymphocytic leukemia. Her Lymphoma research extends to the thematically linked field of Antibody. Her Antigen research is multidisciplinary, relying on both Cytotoxic T cell and Virology.
Her work in Molecular biology addresses issues such as Gene, which are connected to fields such as Follicular lymphoma and DNA. Her Chronic lymphocytic leukemia research includes elements of Cancer research, breakpoint cluster region and B-cell receptor. Her research integrates issues of Apoptosis and Phosphorylation in her study of Cancer research.
Her main research concerns Cancer research, Immunology, Chronic lymphocytic leukemia, Antigen and IGHV@. The concepts of her Cancer research study are interwoven with issues in Cell culture, CD19, Interleukin 4, PI3K/AKT/mTOR pathway and Kinase. Her study looks at the relationship between Immunology and topics such as Phenotype, which overlap with Mutation.
The study incorporates disciplines such as breakpoint cluster region, B-cell receptor and Signal transduction in addition to Chronic lymphocytic leukemia. As part of the same scientific family, Freda K. Stevenson usually focuses on Antigen, concentrating on Molecular biology and intersecting with Surface Immunoglobulin, Mannose, Glycosylation, Peptide sequence and Gene. Her IGHV@ study also includes fields such as
Freda K. Stevenson mostly deals with Immunology, Chronic lymphocytic leukemia, Cancer research, breakpoint cluster region and Antibody. Her Immunology research focuses on Antigen and Cytokine. Freda K. Stevenson works on Chronic lymphocytic leukemia which deals in particular with IGHV@.
Her Cancer research study deals with B-cell receptor intersecting with Ibrutinib, Translational regulation, Protein biosynthesis, eIF4A and Translation. Her breakpoint cluster region research focuses on Cell biology and how it relates to Clone, Follicular lymphoma, Chromatin, B cell and Germinal center. Her work investigates the relationship between Antibody and topics such as Vaccination that intersect with problems in DNA vaccination, Cancer, Multiple myeloma and ELISPOT.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.
Terry J. Hamblin;Zadie Davis;Zadie Davis;Anne Gardiner;Anne Gardiner;David G. Oscier;David G. Oscier.
CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.
Terry J. Hamblin;Jenny A. Orchard;Rachel E. Ibbotson;Zadie Davis.
Chronic lymphocytic leukemia : revelations from the B-cell receptor
Freda K. Stevenson;Federico Caligaris-Cappio.
DNA vaccines: precision tools for activating effective immunity against cancer.
Jason Rice;Christian H. Ottensmeier;Freda K. Stevenson.
Nature Reviews Cancer (2008)
DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma
Catherine A. King;Myfanwy B. Spellerberg;Delin Zhu;Jason Rice.
Nature Medicine (1998)
Chronic lymphocytic leukaemia.
Thomas J. Kipps;Freda K. Stevenson;Catherine J. Wu;Carlo M. Croce.
Nature Reviews Disease Primers (2017)
B-cell receptor signaling in chronic lymphocytic leukemia
Freda K. Stevenson;Sergey Krysov;Andrew J. Davies;Andrew J. Steele.
Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia.
Stuart Lanham;Terry Hamblin;David Oscier;Rachel Ibbotson.
Differential Rates of Somatic Hypermutation in VH Genes Among Subsets of Chronic Lymphocytic Leukemia Defined by Chromosomal Abnormalities
David G. Oscier;Andrew Thompsett;Andrew Thompsett;Delin Zhu;Delin Zhu;Freda K. Stevenson;Freda K. Stevenson.
Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status.
C. Ian Mockridge;Kathleen N. Potter;Isla Wheatley;Louise A. Neville.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: